2-218428036-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_007127.3(VIL1):āc.419T>Cā(p.Leu140Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000954 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 32)
Exomes š: 0.000090 ( 0 hom. )
Consequence
VIL1
NM_007127.3 missense
NM_007127.3 missense
Scores
12
5
2
Clinical Significance
Conservation
PhyloP100: 6.12
Genes affected
VIL1 (HGNC:12690): (villin 1) This gene encodes a member of a family of calcium-regulated actin-binding proteins. This protein represents a dominant part of the brush border cytoskeleton which functions in the capping, severing, and bundling of actin filaments. Two mRNAs of 2.7 kb and 3.5 kb have been observed; they result from utilization of alternate poly-adenylation signals present in the terminal exon. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VIL1 | NM_007127.3 | c.419T>C | p.Leu140Pro | missense_variant | 5/20 | ENST00000248444.10 | NP_009058.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VIL1 | ENST00000248444.10 | c.419T>C | p.Leu140Pro | missense_variant | 5/20 | 1 | NM_007127.3 | ENSP00000248444 | P1 | |
VIL1 | ENST00000440053.1 | c.419T>C | p.Leu140Pro | missense_variant | 4/9 | 1 | ENSP00000409270 | |||
VIL1 | ENST00000454069.5 | c.407T>C | p.Leu136Pro | missense_variant | 5/6 | 3 | ENSP00000412657 | |||
VIL1 | ENST00000392114.6 | c.-183-1432T>C | intron_variant | 2 | ENSP00000375962 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152128Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
22
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251414Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135876
GnomAD3 exomes
AF:
AC:
20
AN:
251414
Hom.:
AF XY:
AC XY:
10
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000903 AC: 132AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 77AN XY: 727244
GnomAD4 exome
AF:
AC:
132
AN:
1461880
Hom.:
Cov.:
31
AF XY:
AC XY:
77
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000145 AC: 22AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74322
GnomAD4 genome
AF:
AC:
22
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2021 | The c.419T>C (p.L140P) alteration is located in exon 5 (coding exon 4) of the VIL1 gene. This alteration results from a T to C substitution at nucleotide position 419, causing the leucine (L) at amino acid position 140 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;.;H
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Loss of stability (P = 0.0132);.;Loss of stability (P = 0.0132);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at